Kristin M. Zimmerman Savill

Author

Also Known As

K Savill, K. Savill, K. Zimmerman, K.M. Zimmerman Savill, Kristin M Zimmerman Savill, Kristin M. Savill, Kristin M. Zimmerman, Kristin M. Zimmerman Savill, Kristin Zimmerman, Kristin Zimmerman Savill

Publications

724

Citations

H-Index

Concepts

All Affiliations

Yale University Universität Hamburg Sunesis (United States)University Medical Center Hamburg-Eppendorf National Institutes of Health

About

Kristin M. Zimmerman Savill is an author at Yale University specializing in medicine, cell biology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	294
2	Cell Biology	3	3	215
3	Pharmacology	2	2	107
4	Health Sciences	1	1	42
5	Cell Signaling	1	1	107

Kristin M. Zimmerman Savill

Publications

650

Citations

H-Index

Page 1

	Year	Citations
DNA double-strand break repair defects in syndromes associated with acute radiation response: At least two different assays to predict intrinsic radiosensitivity? Aurélie Joubert, Kristin M. Zimmerman Savill, Zuzana Bencokova, International Journal of Radiation Biology	2008	119
Discovery of a potent and selective Aurora kinase inhibitor Johan D. Oslob, M.J. Romanowski, Darin A. Allen, Bioorganic & Medicinal Chemistry Letters Signaling PathwayReceptor Tyrosine KinaseMedicineCell BiologyCell Signaling	2008	107
SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivo Jennifer P. Arbitrario, Brian J. Belmont, Marc Evanchik, Cancer Chemotherapy and Pharmacology Potent Anti-tumor ActivityNovel TherapyMedicineReceptor Tyrosine KinaseImmune Checkpoint Inhibitor	2009	66
Human Heterozygous ENPP1 Deficiency Is Associated With Early Onset Osteoporosis, a Phenotype Recapitulated in a Mouse Model of Enpp1 Deficiency Ralf Oheim, Kristin M. Zimmerman Savill, Nathan D Maulding, Journal of Bone and Mineral Research	2019	59
Clinical and Biochemical Phenotypes in a Family With <i>ENPP1</i> Mutations Anupam Kotwal, Alejandro Ferrer, Rajiv Kumar, Journal of Bone and Mineral Research	2019	45
Diminished Origin-Licensing Capacity Specifically Sensitizes Tumor Cells to Replication Stress Kristin M. Zimmerman Savill, Rebecca M. Jones, Eva Petermann, Molecular Cancer Research Tumor BiologyCell RegulationTumor HeterogeneityMedicineOncogenic Agent	2013	42
2-Aminobenzimidazoles as potent Aurora kinase inhibitors Min Zhong, Minna Bui, Shen Wang, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicinePharmacotherapyAnti-cancer AgentPharmacology	2009	41
Genetic pathways disrupted by ENPP1 deficiency provide insight into mechanisms of osteoporosis, osteomalacia, and paradoxical mineralization Nathan D Maulding, Dillon Kavanagh, Kristin M. Zimmerman Savill, Bone Bone DiseaseSclerostinDevelopmental BiologyGeneticsEnpp1 Deficiency Provide	2020	38
Distinct resistance mechanisms arise to allosteric vs. ATP-competitive AKT inhibitors Kristin M. Zimmerman Savill, Brian B. Lee, Jason Oeh, Nature Communications	2022	32
Response of the ENPP1-Deficient Skeletal Phenotype to Oral Phosphate Supplementation and/or Enzyme Replacement Therapy: Comparative Studies in Humans and Mice Carlos R. Ferreira, Dillon Kavanagh, Ralf Oheim, Journal of Bone and Mineral Research	2020	29

Page 1